Yum China (9987.HK) traded up 3.08 % during a 24 hours period ending at 11:39 PM Central Europe on Monday 26th. One Yum China stock can currently be bought for about HKD 352.4 on popular exchanges. Current supply of Yum China stocks is 1 bn. Yum China has a current market capitalization of HKD 358.9 bn and approximately HKD 476.2 mn worth of Yum China was traded on exchanges in the last 24 hours. Since last month end, Yum China has traded 10 % up. Simple moving average of last 200 days is at HKD 367.77. The highest price of past 52 weeks was recorded at HKD 451.2 on 02/10/2026. 52 weeks low was at HKD 310.6 on 10/05/2026.

Summary of the latest news for Yum China

YUM CHINA Holdings Inc. announced a share‑buyback program that included purchases on both the Hong Kong and New York exchanges. The company repurchased 24,000 Hong Kong‑listed shares at a price near HKD340 to HKD347, and 60,500 ADRs on the New York Stock Exchange at a price close to USD44.40 to USD44.75. The repurchase effort, approved by the company’s board, brings the total shares repurchased to roughly 9.48 million, representing a small but notable fraction of the issued shares. This activity reflects YUM CHINA’s ongoing strategy to manage capital and support its stock in a stable market environment.

Here is how related stocks have performed in the past 24 hours:

  • Picc Property & Casualty-h (2328.HK) traded up 1.67 % and now trades at HKD 15.44. Picc Property & Casualty-h has a market capitalisation of HKD 338.8 bn. Picc Property & Casualty-h has a current price to earnings ratio of 5.97.

  • Wuliangye Yibin (000858.SZ) traded flat 0 % and now trades at CNY 75.63. Wuliangye Yibin has a market capitalisation of CNY 286.7 bn. Current price/earnings ratio for Wuliangye Yibin is 132.92. Financial analysts noted that WULIANGYE YIBIN CO LTD, a leading producer of high‑grade baijiu, has recently reported modest performance in its third‑quarter earnings. The company’s revenues are projected to show a slight decline, consistent with broader industry trends driven by reduced sales during the national holiday period. While overall sales volume has contracted, the firm is expected to maintain its focus on high‑margin product lines, which may help offset the downward pressure on volume. Market observers anticipate that, as the industry shifts toward a more balanced supply–demand environment, companies with stronger brand positioning and efficient cost management—such as WULIANGYE YIBIN—are likely to gradually improve their earnings relative to peers. The forthcoming earnings release will be closely watched for indications of how the company adapts its pricing and distribution strategy in response to the current market slowdown.

  • Jiangsu Hengrui Pharmaceut-h (1276.HK) traded up 0.67 % and now trades at HKD 47.14. Jiangsu Hengrui Pharmaceut-h has a market capitalisation of HKD 364 bn. Jiāngsū Hēngrùi Yīpǐn, a listed pharmaceutical company in China, has recently reported financial results that highlight a shift in industry focus toward performance and value creation. According to a market‑wide report released during the 11th Innovation Drug & Investment Conference, the Chinese biopharmaceutical sector has moved from a pipeline‑centric narrative to a greater emphasis on commercial outcomes and earnings delivery. The company’s disclosures reflect this trend, with management noting the importance of aligning research and development efforts with clear market potential and regulatory pathways. Investors have observed that while overall sector market value has declined, the number of listed firms has increased, indicating a maturing landscape that rewards firms capable of demonstrating tangible progress. The company’s recent filings also underscore its commitment to adopting advanced tools, including artificial intelligence, to accelerate development and improve valuation transparency.

  • East Money Information (300059.SZ) traded flat 0 % and now trades at CNY 18.57. East Money Information has a market capitalisation of CNY 293.5 bn. East Money Information has a current price to earnings ratio of 20.1. EAST MONEY INFORMATION CO experienced a modest uptick in trading activity in the first half of the day, with a noticeable influx of institutional capital. The company’s shares were among the leading recipients of net buying in the robotic and artificial‑intelligence sectors, reflecting continued investor interest in its technology offerings. While the stock did not reach a formal price limit, the volume surge suggests growing confidence in its business prospects. No significant corporate announcements or earnings reports were disclosed during the session, so the price movement appears to be driven primarily by market demand rather than new information.

  • Citic (0267.HK) traded up 0.93 % and now trades at HKD 11.94. Current market capitalisation for Citic is HKD 346.8 bn. Current price/earnings ratio for Citic is 4.85.

About Yum China

Yum China Holdings, Inc. is a restaurant chain operating globally, offering a diverse range of cuisine including pizza, entrees, pasta, rice dishes, appetizers, soups, vegetables, beverages, and desserts.